Latest reported quarter: Q2, ended Jun 2026
| Line item | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $87.47M | $74.39M | $275.74M | $72.57M | $73.08M |
| Total Operating Revenue | $87.47M | $74.39M | $275.74M | $72.57M | $73.08M |
| Cost of Revenue | $44.43M | $40.70M | $176.68M | $42.06M | $44.28M |
| Gross Profit | $43.04M | $33.69M | $99.06M | $30.51M | $28.79M |
| Operating Expense | $7.13M | $7.22M | $33.69M | $11.79M | $7.54M |
| Selling and Admin Expenses | $7.13M | $7.22M | $29.85M | $7.96M | $7.54M |
| -General & Admin Expense | $7.13M | $7.22M | $29.85M | $7.96M | $7.54M |
| Operating Profit | $35.91M | $26.47M | $65.37M | $18.71M | $21.25M |
| Net Non-Operating Interest Income (Expense) | -$5.30M | -$5.74M | -$28.69M | -$6.64M | -$7.38M |
| Non-Operating Interest Income | $1.59M | $1.54M | $5.12M | $1.64M | $1.15M |
| Non-Operating Interest Expense | $6.08M | $6.54M | $30.34M | $7.51M | $7.59M |
| Total Other Finance Costs | $807,000.00 | $748,000.00 | $3.46M | $772,000.00 | $933,000.00 |
| Other Income (Expense) | $4.55M | $1.48M | $1.88M | -$236,000.00 | $3.91M |
| Gain on Sale of Security | $441,000.00 | $1.48M | -$2.72M | -$236,000.00 | -$686,000.00 |
| Special Income (Charges) | $4.11M | – | $4.60M | $0.00 | $4.60M |
| -Gain on Sale of Property/Plant/Equipment | $4.11M | – | $4.60M | $0.00 | $4.60M |
| Pretax Profit | $35.16M | $22.21M | $38.56M | $11.84M | $17.78M |
| Net Profit | $35.16M | $22.21M | $38.56M | $11.84M | $17.78M |
| Profit from Continuing Operations | $35.16M | $22.21M | $38.56M | $11.84M | $17.78M |
| Net Income to Parent Company | $35.16M | $22.21M | $38.56M | $11.84M | $17.78M |
| Preferred Stock Dividends | $2.00M | $2.00M | $8.00M | $2.00M | $2.00M |
| Net Income to Common Stockholders | $33.16M | $20.21M | $30.56M | $9.84M | $15.78M |
| Basic EPS | $0.33 | $0.20 | $0.30 | $0.10 | $0.15 |
| Diluted EPS | $0.33 | $0.20 | $0.30 | $0.10 | $0.15 |
| Dividend Per Share | $0.06 | $0.05 | $0.20 | $0.05 | $0.05 |
| Other Operating Expenses | – | – | $3.84M | – | – |
| Line item | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| Total Assets | $1.43B | $1.42B | $1.40B | $1.40B | $1.37B |
| Total Current Assets | $211.35M | $249.41M | $200.60M | $200.60M | $158.95M |
| Cash and Cash Equivalents & Short-Term Investments | $134.54M | $171.78M | $157.96M | $157.96M | $115.25M |
| -Cash and Cash Equivalents | $43.74M | – | $141.58M | $141.58M | – |
| -Short Term Investments | $90.80M | – | $16.38M | $16.38M | – |
| Other Current Assets | $55.88M | $47.40M | $5.36M | $5.36M | $43.71M |
| Total Non-Current Assets | $1.22B | $1.17B | $1.20B | $1.20B | $1.21B |
| Net PPE | $1.21B | $1.16B | $1.19B | $1.19B | $1.20B |
| -Gross PPE | $1.21B | $1.16B | $1.71B | $1.71B | $1.20B |
| Other Non-Current Assets | $9.99M | $9.85M | $9.70M | $9.70M | $15.54M |
| Total Liabilities | $558.89M | $577.21M | $572.48M | $572.48M | $546.33M |
| Total Current Liabilities | $210.86M | $181.41M | $69.06M | $69.06M | $58.53M |
| Short-Term Debt and Capital Lease Obligation | $171.56M | $155.06M | $42.37M | $42.37M | $34.50M |
| -Current Debt | $171.56M | $155.06M | $42.37M | $42.37M | $34.50M |
| Other Current Liabilities | $39.30M | $26.35M | $208,000.00 | $208,000.00 | $24.03M |
| Total Non-Current Liabilities | $348.02M | $395.80M | $503.42M | $503.42M | $487.81M |
| Long Term Debt and Capital Lease Obligation | $339.88M | $388.94M | $497.77M | $497.77M | $481.78M |
| -Long Term Debt | $339.88M | $388.94M | $497.77M | $497.77M | $481.78M |
| Other Non-Current Liabilities | $8.14M | $6.87M | $3.31M | $3.31M | $6.03M |
| Total Equity | $870.28M | $843.19M | $830.71M | $830.71M | $826.28M |
| Stockholders' Equity | $870.28M | $843.19M | $830.71M | $830.71M | $826.28M |
| Receivables | – | – | $11.79M | $11.79M | – |
| -Accounts Receivable | – | – | $8.85M | $8.85M | – |
| -Other Receivables | – | – | $2.94M | $2.94M | – |
| Inventory | – | – | $19.01M | $19.01M | – |
| Restricted Cash | – | – | $0.00 | $0.00 | – |
| -Accumulated Depreciation | – | – | -$518.82M | -$518.82M | – |
| Financial Assets | – | – | $0.00 | $0.00 | – |
| Payables | – | – | $13.40M | $13.40M | – |
| -Accounts Payable | – | – | $13.37M | $13.37M | – |
| -Other Payable | – | – | $27,000.00 | $27,000.00 | – |
| Current Accrued Expenses | – | – | $7.86M | $7.86M | – |
| Current Deferred Liabilities | – | – | $5.22M | $5.22M | – |
| Derivative Product Liabilities | – | – | $27,000.00 | $27,000.00 | – |
| Non-Current Deferred Liabilities | – | – | $2.31M | $2.31M | – |
| Capital Stock | – | – | $142,000.00 | $142,000.00 | – |
| -Common Stock | – | – | $102,000.00 | $102,000.00 | – |
| -Preferred Stock | – | – | $40,000.00 | $40,000.00 | – |
| Additional Paid-In Capital | – | – | $313.28M | $313.28M | – |
| Retained Earnings | – | – | $517.29M | $517.29M | – |
| Line item | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| Operating Cash Flow | $42.68M | $35.20M | $102.29M | $33.19M | $20.08M |
| Net cash flow from investing | -$39.74M | -$98.80M | $9.70M | -$4.20M | $37.87M |
| Financing Cash Flow | -$34.27M | -$4.20M | -$52.37M | $15.73M | -$43.83M |
| Free Cash Flow | -$16.53M | $35.20M | $60.30M | -$8.80M | $51.41M |
| Net cash flow from continuing operations | – | – | $102.29M | – | – |
| Net Income from Continuing Operations | – | – | $38.56M | – | – |
| Gain/Loss from Continuing Operations | – | – | $1.52M | – | – |
| Depreciation & Depletion & Amortization | – | – | $59.88M | – | – |
| Other Non-Cash Items | – | – | $6.59M | – | – |
| Change in Working Capital | – | – | -$4.40M | – | – |
| -Change in Receivables | – | – | $3.29M | – | – |
| -Change in Inventory | – | – | -$7.96M | – | – |
| -Change in Prepaid Assets | – | – | $1.65M | – | – |
| -Change in Payables and Accrued Expense | – | – | -$559,000.00 | – | – |
| -Change In Other Working Capital | – | – | -$820,000.00 | – | – |
| Net Cash Flow from Continuing Investing Activities | – | – | $9.70M | – | – |
| Net PPE Purchase and Sale | – | – | -$18.60M | – | – |
| Net Investment Purchase and Sale | – | – | $28.30M | – | – |
| Net Cash Flow from Continuing Financing Activities | – | – | -$52.37M | – | – |
| Net Issuance Payments Of Debt | – | – | -$10.54M | – | – |
| Net Common Stock Issuance | – | – | -$11.01M | – | – |
| Cash Dividends Paid | – | – | -$28.61M | – | – |
| Net Other Financing Charges | – | – | -$2.21M | – | – |
| Ending Cash Balance | – | – | $151.25M | – | – |
| Net Change in Cash | – | – | $59.62M | – | – |
| Beginning Cash Balance | – | – | $91.56M | – | – |
| Effect of Exchange Rate Changes | – | – | $75,000.00 | – | – |
No comments yet — be the first to weigh in on SB.